TCM
Tekla Capital Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-41,577
| Closed | -$1.08M | – | 206 |
|
|
2020
Q4 | $1.08M | Hold |
41,577
| – | – | 0.04% | 176 |
|
|
2020
Q3 | $1.55M | Hold |
41,577
| – | – | 0.06% | 165 |
|
|
2020
Q2 | $2.13M | Hold |
41,577
| – | – | 0.08% | 156 |
|
|
2020
Q1 | $1.31M | Sell |
41,577
-171,985
| -81% | -$5.42M | 0.06% | 159 |
|
|
2019
Q4 | $12.7M | Hold |
213,562
| – | – | 0.48% | 45 |
|
|
2019
Q3 | $7.83M | Buy |
213,562
+28,955
| +16% | +$1.06M | 0.34% | 59 |
|
|
2019
Q2 | $8.59M | Hold |
184,607
| – | – | 0.35% | 64 |
|
|
2019
Q1 | $7.41M | Buy |
184,607
+42,318
| +30% | +$1.7M | 0.3% | 70 |
|
|
2018
Q4 | $6.55M | Sell |
142,289
-46,998
| -25% | -$2.16M | 0.28% | 72 |
|
|
2018
Q3 | $8.4M | Hold |
189,287
| – | – | 0.3% | 73 |
|
|
2018
Q2 | $7.42M | Hold |
189,287
| – | – | 0.28% | 78 |
|
|
2018
Q1 | $13.7M | Buy |
+189,287
| New | +$13.7M | 0.53% | 43 |
|
|
2017
Q1 | – | Sell |
-102,800
| Closed | -$1.29M | – | 142 |
|
|
2016
Q4 | $1.29M | Hold |
102,800
| – | – | 0.05% | 123 |
|
|
2016
Q3 | $1.42M | Hold |
102,800
| – | – | 0.05% | 127 |
|
|
2016
Q2 | $1.02M | Hold |
102,800
| – | – | 0.04% | 131 |
|
|
2016
Q1 | $1.74M | Hold |
102,800
| – | – | 0.07% | 125 |
|
|
2015
Q4 | $2.29M | Hold |
102,800
| – | – | 0.08% | 117 |
|
|
2015
Q3 | $2.43M | Sell |
102,800
-45,200
| -31% | -$1.07M | 0.09% | 114 |
|
|
2015
Q2 | $12.1M | Buy |
+148,000
| New | +$12.1M | 0.44% | 46 |
|